1. Home
  2. WST vs BR Comparison

WST vs BR Comparison

Compare WST & BR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • BR
  • Stock Information
  • Founded
  • WST 1923
  • BR 1962
  • Country
  • WST United States
  • BR United States
  • Employees
  • WST N/A
  • BR N/A
  • Industry
  • WST Medical/Dental Instruments
  • BR Business Services
  • Sector
  • WST Health Care
  • BR Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • BR Nasdaq
  • Market Cap
  • WST 18.0B
  • BR 26.7B
  • IPO Year
  • WST N/A
  • BR 2007
  • Fundamental
  • Price
  • WST $279.76
  • BR $232.85
  • Analyst Decision
  • WST Strong Buy
  • BR Buy
  • Analyst Count
  • WST 8
  • BR 7
  • Target Price
  • WST $333.71
  • BR $261.50
  • AVG Volume (30 Days)
  • WST 619.1K
  • BR 530.6K
  • Earning Date
  • WST 10-23-2025
  • BR 11-04-2025
  • Dividend Yield
  • WST 0.32%
  • BR 1.68%
  • EPS Growth
  • WST N/A
  • BR 21.16
  • EPS
  • WST 6.68
  • BR 7.10
  • Revenue
  • WST $2,960,200,000.00
  • BR $6,889,100,000.00
  • Revenue This Year
  • WST $6.28
  • BR $8.16
  • Revenue Next Year
  • WST $6.11
  • BR $5.22
  • P/E Ratio
  • WST $41.80
  • BR $32.72
  • Revenue Growth
  • WST 2.90
  • BR 5.88
  • 52 Week Low
  • WST $187.43
  • BR $208.20
  • 52 Week High
  • WST $352.33
  • BR $271.91
  • Technical
  • Relative Strength Index (RSI)
  • WST 68.85
  • BR 42.30
  • Support Level
  • WST $260.12
  • BR $225.62
  • Resistance Level
  • WST $265.66
  • BR $235.92
  • Average True Range (ATR)
  • WST 5.66
  • BR 3.64
  • MACD
  • WST 0.63
  • BR 0.26
  • Stochastic Oscillator
  • WST 90.76
  • BR 55.15

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About BR Broadridge Financial Solutions Inc.

Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communication and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two operating segments: investor communication solutions and global technology and operations.

Share on Social Networks: